These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28861951)

  • 1. Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response.
    Xie J; Yang C; Liu Q; Li J; Liang R; Shen C; Zhang Y; Wang K; Liu L; Shezad K; Sullivan M; Xu Y; Shen G; Tao J; Zhu J; Zhang Z
    Small; 2017 Oct; 13(40):. PubMed ID: 28861951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma.
    Zhuang X; Wu T; Zhao Y; Hu X; Bao Y; Guo Y; Song Q; Li G; Tan S; Zhang Z
    J Control Release; 2016 Apr; 228():26-37. PubMed ID: 26921522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.
    Kong M; Tang J; Qiao Q; Wu T; Qi Y; Tan S; Gao X; Zhang Z
    Theranostics; 2017; 7(13):3276-3292. PubMed ID: 28900509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimine Hybrid Thin-Shell Hollow Mesoporous Silica Nanoparticles as Vaccine Self-Adjuvants for Cancer Immunotherapy.
    Liu Q; Zhou Y; Li M; Zhao L; Ren J; Li D; Tan Z; Wang K; Li H; Hussain M; Zhang L; Shen G; Zhu J; Tao J
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47798-47809. PubMed ID: 31773941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
    She X; Chen L; Velleman L; Li C; Zhu H; He C; Wang T; Shigdar S; Duan W; Kong L
    J Colloid Interface Sci; 2015 May; 445():151-160. PubMed ID: 25617610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine.
    Lee JY; Kim MK; Nguyen TL; Kim J
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34658-34666. PubMed ID: 32662625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
    Geng H; Chen W; Xu ZP; Qian G; An J; Zhang H
    Chemistry; 2017 Aug; 23(45):10878-10885. PubMed ID: 28580592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier.
    Xu H; Zhang H; Wang D; Wu L; Liu X; Jiao Z
    J Colloid Interface Sci; 2015 Aug; 451():101-7. PubMed ID: 25890118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy.
    Shen J; Song G; An M; Li X; Wu N; Ruan K; Hu J; Hu R
    Biomaterials; 2014 Jan; 35(1):316-26. PubMed ID: 24125776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile synthesis of monodisperse of hollow mesoporous SiO2 nanoparticles and in-situ growth of Ag nanoparticles for antibacterial.
    Xu P; Liang J; Cao X; Tang J; Gao J; Wang L; Shao W; Gao Q; Teng Z
    J Colloid Interface Sci; 2016 Jul; 474():114-8. PubMed ID: 27115332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery.
    Zhang Z; Tongchusak S; Mizukami Y; Kang YJ; Ioji T; Touma M; Reinhold B; Keskin DB; Reinherz EL; Sasada T
    Biomaterials; 2011 May; 32(14):3666-78. PubMed ID: 21345488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dacarbazine-Loaded Hollow Mesoporous Silica Nanoparticles Grafted with Folic Acid for Enhancing Antimetastatic Melanoma Response.
    Liu Q; Xu N; Liu L; Li J; Zhang Y; Shen C; Shezad K; Zhang L; Zhu J; Tao J
    ACS Appl Mater Interfaces; 2017 Jul; 9(26):21673-21687. PubMed ID: 28590113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma.
    Nejabat M; Mohammadi M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Carbohydr Polym; 2018 Oct; 197():157-166. PubMed ID: 30007600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
    Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
    ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H2A-peptide-hybrided upconversion mesoporous silica nanoparticles for bortezomib/p53 delivery and apoptosis induction.
    Rong J; Li P; Ge Y; Chen H; Wu J; Zhang R; Lao J; Lou D; Zhang Y
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110674. PubMed ID: 31855686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical mesoporous silica nanoparticles for tailorable drug release.
    Wu W; Ye C; Xiao H; Sun X; Qu W; Li X; Chen M; Li J
    Int J Pharm; 2016 Sep; 511(1):65-72. PubMed ID: 27374197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.